Navigation Links
CLEARGLIDE ACCEL EVH System

ProductsCLEARGLIDE ACCEL EVH System
Company CardioVations
Item CLEARGLIDE ACCEL EVH System
Features 
  • Controlled coagulation and cutting in one step
  • Significantly less thermal spread than traditional bipolar scissors (2.4 .33 mm vs 3.4 1.3 mm; P<0.05)
  • Unique offset electrode design reduces thermal injuries that might compromise graft vessel and surrounding tissue
  • Designed to increase working space from main vessel
  • Superior results with less trauma, reduced wound morbidity, and fewer complicationsVessel integrity equivalent to vessel harvest with open procedure
  • Description The CLEARGLIDE Optical Vessel Dissector has application for use in the creation of an operative cavity in the extraperitoneal spaces such as the retroperitoneal, preperitoneal, and subcutaneous areas. The device may be used in surgical procedures requiring dissection of tissue. The EVH system enables harvesting of a quality conduit through a single leg incision. It offers precision and control of an integrated system. And the open CO2 system is not dependent on gas insufflation to maintain tissue separation. Additionally it provides flexibility to support a variety of clinical approaches.
    Info CardioVations
    Customer Service: (800) ETHICON
    Web site: http://www.cardiovations.com/

    Related medicine products :

    1. Silicone Oil Cannula System - 20 Gauge
    2. Silicone Oil Cannula System - 19 Gauge
    3. SuperVu Galilean System
    4. KOWA nonmyd 7 / VK-2 Digital Imaging System
    5. KOWA nonmyd a-D / VK-2 Digital Imaging System
    6. Refraction System RT-2100
    7. Odyssey Phacoemulsification System
    8. SIStem Phacoemulsification System
    9. Precisionist Phacoemulsification System
    10. Photon Laser Phacoemulsification System
    11. Phaco-Emulsification System
    For the quantitative in vitro determination of Total Protein in serum and plasma...
    The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
    Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
    For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
    Medicine Products:
    (Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
    (Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
    (Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
    (Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
    (Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
    Breaking Medicine News(10 mins):
    (Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
    (Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
    (Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
    Breaking Medicine Technology: